Christian Weyer, EVP, Research & Development at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 1,550 shares at $85.00 ($132K) on 2019-11-19, disclosed to the SEC on 2019-11-19.
Open-market sale of $132k ICPT by EVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ICPT | SELL | 2020-01-27 | $136K | — | Filing → |
| ICPT | SELL | 2019-12-30 | $390K | — | Filing → |
| ICPT | SELL | 2019-12-02 | $106K | — | Filing → |